Transforming drug discovery
Greenstone Bio is a commercial stage computational biology company specializing in stem cell technology, artificial intelligence & machine learning, and drug discovery. The company’s drug discovery platform is fueled by an exceptional data trove, augmented with machine learning, and grounded by stem cell biology. Greenstone Bio has established extensive knowledge and expertise in generating patient-derived human iPSCs and differentiation into numerous cell types for disease modeling and drug discovery. The company is co-founded by Dr. Joseph C. Wu, a board-certified cardiologist who is Director of the Stanford Cardiovascular Institute and Professor of Medicine and Radiology at the Stanford University School of Medicine, and by Jade Chao, a patent attorney who is well versed in human iPSC biology.